The expansion aims to enhance access to clinical studies and reinforce the island’s position as a hub for biomedical research. #NewsismyBusiness ...

An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence technologies to generate antibody therapies against any antigen target of interest.

Craft Capital Management LLC acted as underwriter for the Offering (the “Underwriter”). VCL Law LLP acted as U.S. securities counsel to the Company, and Ortoli Rosenstadt LLP acted as U.S. securities ...

Greenhaven Road Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the ...

Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, diagnosis and staging, and treatment of cancer, today announced the pricing ...

Signs a strategic collaboration and license agreement to advance novel therapies targeting corticotropin-releasing hormone ...

RALEIGH, N.C., Feb. 24, 2025 /PRNewswire/ -- Kineticos Life Sciences announces the launch of Kinvard Bio, Inc., a newly established ... and Response; Biomedical Advanced Research and Development ...

This page features the latest news about the Orchestra Biomed Holdings stock. Motus GI Holdings Appoints Scott Durbin to its Board Motus GI Holdings, Inc., (MOTS) announced the appointment of ...

Under the collaboration agreement, the parties will combine Harbour BioMed's industry-leading technology platform, proprietary dataset and extensive expertise in antibody development with Insilico's ...